Advanced Therapies Europe 2020

29TH - 30TH SEPTEMBER 2020



Qasim Rafiq

Qasim Rafiq

Senior Lecturer in Bioprocessing of Regenerative, Cellular and Gene Therapy, UCL

Dr Qasim Rafiq is an Associate Professor in Cell and Gene Therapy Bioprocessing at University College London. His research activity focuses on the biomanufacture of advanced therapeutics including cell, gene and tissue-based therapy. Dr Rafiq’s currently leads a research portfolio > £2M focused on translational science, specifically process control strategies to drive product consistency.  He is a Chartered Engineering (CEng), a Chartered Scientist (CSci) and is currently pursuing an MBA

  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd